Your Partner in EMS
group000780
Labetalol
Manufacturer:
PFIZER INC.
Regulated product
Non-Returnable Product
Manufacturer:
PFIZER INC.
Product description:
Always follow your local protocols regarding product use.
You are unable to select more than your available quota at this time. Please contact your administrator for assistance.
Added to Your Shopping Cart
Refine results
Dosage
Strength
Color
Application Type
Purpose
Latex Content
Life Stage
Formulation
Active Ingredient
Inactive Ingredient
Route of Administration
Preservative-Free
pH Range
Concentration
Dosage Form
Form
Application
NDC
Grade
Sterile
Container Type
Storage Requirements
Uses
Latex Free
Closure Size
Are you sure you want to clear this supply list?
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| Product # | 0586-29 | 0586-56 | 2267-54 | 372339 | 9622-01 | 2267-20 | 0450-01 | 1911-57673 |
| Dosage | Multi-dose | |||||||
| Strength | 5mg/mL | 5mg/mL | 5mg/mL 200mg/40mL | 5mg/mL 20mg/4mL | 100mg/20mL | 5mg/mL 100mg/20mL | 200mg | |
| Color | Colorless to Light Yellow | Colorless to Light Yellow | Clear, Colorless to Slightly Yellow | Colorless to Light Yellow | ||||
| Application Type | Human Prescription Drug | Human Prescription Drug | Human Prescription Drug | |||||
| Purpose | Beta-Adrenergic Blocking Agent | Beta-Adrenergic Blocking Agent | Beta-Adrenergic Blocking Agent | |||||
| Latex Content | Latex-free | |||||||
| Life Stage | 20mL | 40mL | 40mL | 4mL | 20mL | 20mL | ||
| Formulation | Liquid/Injection Solution | Liquid/Injection Solution | Liquid/Injection Solution | Liquid/Injection Solution | Liquid/Injection Solution | |||
| Active Ingredient | Labetalol, Hydrochloride | Labetalol, Hydrochloride | 5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl) Amino] Ethyl] Salicylamide Monohydrochloride | Labetalol, Hydrochloride | ||||
| Inactive Ingredient | Anhydrous Dextrose, Edetate Disodium, Methylparaben, Propylparaben, Citric Acid Monohydrate, Sodium Hydroxide | |||||||
| Route of Administration | Intravenous | Intravenous | Intravenous | Intravenous | ||||
| Preservative-Free | No | No | No | |||||
| pH Range | 3 to 4.5 | 3 to 4.5 | 3 to 4.5 | |||||
| Concentration | 5mg/mL | |||||||
| Dosage Form | Injection | |||||||
| Form | Solution | Tablet | ||||||
| Application | Adrenergic Receptor Blocking Agent | |||||||
| NDC | 47781-0586-29 | 47781-0586-56 | 00409-2267-54 | 00409-2339-34 | 0143-9622-01 | 00409-2267-20 | 60687-0450-01 | |
| Grade | Usp | Usp | USP | Usp | ||||
| Sterile | Sterile | Sterile | Yes | Sterile | ||||
| Container Type | Vial | Vial | Vial | |||||
| Storage Requirements | 20 to 25°C, USP Controlled Room Temperature, Protect From Freezing and Light | 20 to 25°C, USP Controlled Room Temperature, Protect From Freezing and Light | 20 to 25°C | 20 to 25°C, USP Controlled Room Temperature, Protect From Freezing and Light | ||||
| Uses | Labetalol HCl Injection is Indicated for Control of Blood Pressurein Severe Hypertension | Labetalol HCl Injection is Indicated for Control of Blood Pressurein Severe Hypertension | Labetalol HCl Injection is Indicated for Control of Blood Pressurein Severe Hypertension | |||||
| Latex Free | Yes | |||||||
| Closure Size | 20mm |
Labetalol - Directions for Use